Treating resistant hypertension in type 2 diabetes: a role for spironolactone?

Abstract

Get full access to this article

View all access options for this article.

References

Anon. Spironolactone: No longer for hypertension. Drug Ther Bull 1988 ;26:88.

Johnston LC , Grieble HG Treatment of arterial hypertensive disease with diuretics. V. Spironolactone, an aldosterone antagonist. Arch Intern Med 1967;119:225-31.

Clement DL Effect of spironolactone on systemic blood pressure, limb blood flow and response to sympathetic stimulation in hypertensive patients. Eur J Clin Pharmacol 1992;21:263-7.

Henry M. , Wehrlen M. , Pelletier , Capron MH Spironolactone versus nifedipine in essential hypertension. Am J Cardiol 1990;65:36K-38K.

Schohn DC , Spiesser R. , Wehrlen M. , Pelletier , Capron MH Aldactazine/captopril combination, safe and effective in mild to moderate systemic hypertension: report on a multicenter study of 967 patients. Am J Cardiol 1990;65:4K-6K.

Williams B. , Poulter NR , Brown MJ et al. British Hypertension Society. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 2004;18:139-85.

Ouzan J. , Pérault C. , Lincoff M. , Carré E. , Mertes M. The role of spironolactone in the treatment of patients with refractory hypertension . Am J Hypertens 2002;15:333-9.

Brilla CG , Matsubara LS , Weber KT Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension. Am J Cardiol 1993;71:12A-16A.

Falch DK , Schreiner A. The Effect of Spironolactone on Lipid, Glucose and Uric Acid Levels in Blood during Long-Term Administration to Hypertensives. Acta Med Scand 1983;213:27-30.

10.

Juurlink DN , Mamdani MM , Lee DS et al. Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study. N Engl J Med 2004;351:543-51.

11.

Winer BM , Lubbe WF , Colton T. Antihypertensive actions of diuretics. Comparative study of an aldosterone antagonist and a thiazide, alone and together. JAMA 1968;204:775-9.

12.

Large DM , Carr PH , Laing I. , Davies M. Hyperkalaemia in diabetes mellitus - potential hazards of coexisting hyporeninaemic hypoaldosteronism. Postgrad Med J 1984;60:370-3.